IL-1j, a major stimulator of hyaluronan synthesis in vitro of human peritoneal mesothelial cells: Relevance to peritonitis in CAPD. The effect of several different growth factors and cytokines on the synthesis of hyaluronan (HA) by human peritoneal mesothelial cells (HPMC) was investigated. Growth arrested HPMC synthesized low levels of HA, but co-culture with PDGF-bh, TGF-f31, TNF-a, and IL-6 at a concentration of 10 nglml all increased HA synthesis between two-to three-fold. At the same concentration IL-113 significantly increased the synthesis eight-fold (N = 3; P < 0.05). The effect of IL-1J3 was also dose-and time-dependent and could be totally negated with interleukin-1 receptor antagonist (IL-113 RcA). Non-infected and infected dialysate from patients receiving CAPD was also found to stimulate HA synthesis by HPMC. The levels found with non-infected fluid were 4 >< io dpm/ml (N = 6) and 12.9 X iO dpm/ml Recently we reported on the metabolism of HA in patients receiving continuous ambulatory peritoneal dialysis (CAPD) for the treatment of end-stage renal failure [Ii]. These studies
(N = 6; P < 0.002) and 8.7 >< iO dpm/ml (N = 6; P < 0.003) for infected fluid collected one and two days after the commencement of peritonitis.
IL-1 RcA dramatically reduced the effect of infected but not noninfected dialysate. These results provide new insights into the manner in which HA synthesis is controlled in the mesothelium and suggest that IL-113 is a key cytokine in the inflammatory response in CAPD patients.
Hyaluronan (HA), also known as hyaluronic acid, is an important glycosaminoglycan (GAG) found in the extracellular matrix and at cell surfaces as part of the pericellular matrix [1] [2] [3] . HA is an alternating copolymer of N-acetyl-D-glucosamine and Dglucuronate, that unlike the GAGs found in proteoglycans, is neither sulphated nor covalently attached to a core protein.
However, a number of proteins including link protein [4] , hyaluronectin [5] , and the core proteins of aggrecan [6] and versican [7, 8] have specific affinity for HA. In addition two cell-surface receptors for HA have been cloned [9, 101. HA plays a critical role in joint function and is responsible for the rheological and viscoelastic properties of synovial fluid. In addition to these physical properties, HA has been implicated in cell locomotion during embryogenesis, tumor invasion and in response to injury [11. HA is also thought to play a critical role in tissue remodeling after injury and in the inflammatory process.
showed that the process of CAPD results in an increase in HA levels in the peritoneal cavity and that during episodes of peritonitis these levels are significantly augmented. While the cellular origins of HA in normal or infected peritoneum were not investigated the serum levels of HA in the CAPD patients were considered too low to account for the increased concentrations in the fluid during bacterial infection. The probable source of the increased HA in the dialysate is therefore likely to be the peritoneal mesothelia! cell. These cells in vitro synthesize HA, very little of which is retained by the cell but is secreted into the culture medium. Furthermore, in an experimental model of inflamed peritoneum in the guinea pig, it was shown that cells of the mesentrium synthesize HA, and that inflammatory changes in the peritoneal lining are critical to the initiation of increased HA production [12] .
The molecular mechanism of regulation of the production of HA in the peritoneum is unknown, but many agents have effects on HA synthesis in pleural mesothelial cells and fibroblasts [13] [14] [15] [16] . Principal among these agents are growth factors, including platelet derived growth factor (PDGF), basic fibroblast growth factor (bFGF), transforming growth factor (TGF) /3 and epiderma! growth factor (EGF). In addition, the regulation of lung fibroblast glycosaminoglycan (GAG) production including HA appears to be influenced by interferons, tumor necrosis factor (TNF-cx) and lymphotoxin [13] . These observations have led us to speculate that growth factors and eytokines may be important regulators of the levels and quantity of HA in the peritoneum.
Consequently, we have investigated the effect of several peptides and dialysate from patients receiving CAPD on the synthesis by human peritonea! mesothelial cells (HPMC) of HA in vitro. The results suggest that interleukin-1f3 (IL-1[3) has a pronounced effect on HA by HPMC and emphasize the potential role of this cytokine in the control of HA in the peritoneum.
Methods

Clinical material
The samples of spent dialysis fluid used in this study were all from patients receiving treatment for end-stage kidney failure by CAPD in the Renal Unit, Royal Infirmary, Cardiff, Wales. Six samples were from patients when free of infection (referred to as non-infected fluid) and six during an episode of peritonitis (referred to as infected fluid). They were aged 18 to 84 years. Samples were taken from overnight dwell (8 to 10 hr) bags. The samples were centrifuged at 1000 g for 10 minutes to remove debris, and then the clear supernatant was aliquoted and stored at -20°C until used in the co-culture experiments. For some experiments two pooled samples were prepared. This was achieved by pooling 0.5 ml of each sample from non-infected (N = 6) and infected fluids (N 6), respectively.
Culture and radiolabeling of mesothelial cells.
Human peritoneal mesothelial cells (FIPMC) were isolated from human omentum and cultured essentially as reported by us previously [171, except that the medium was Medium 199 (Gibco, Paisley, Scotland, UK), which contained 10% fetal calf serum (FCS, Gibco) and was supplemented with hydrocortisone (Sigma Ltd, Poole, UK). For radiolabeling, cells were seeded at a density of 2 X 105/cm2 in 24-well culture plates (Falcon), incubated until confluent, growth arrested in serum-free medium for 48 hours, and then labeled for 24 hours with fresh serum-free medium containing D-[6-3H]-glucosamine hydrochloride (25 LCi/ml; sp.act. 20 Ci/mmol, Amersham International UK). The medium was then removed and retained and the cell layer washed with Medium 199 without serum or radioisotope, the washings being added to the medium. The cell medium and the cell layer both were digested with papain (20 g/ml in 0.2 M sodium acetate, pH 5.8 buffer) for 16 hours at 60°C and the products analyzed on a Mono-Q anion exchange column (Pharmacia), equilibrated with urea buffer comprising 8 M urea, 0.15 M NaCl, 20 mrvi Bis-Tris, pH 6.0, containing 0.1% (wt/vol) CHAPS and interfaced with an fplc system (Pharmacia). The column was developed with a linear gradient of NaCI in urea buffer and fractions (0.5 ml) were collected and analyzed for radioactivity. The material, which eluted between 0.3 to 0.4 M NaCl contained the newly synthesized [3H]-HA [8] . To confirm the presence of HA metabolism and to estimate its molecular size, samples were passed over an analytical Sephacryl-500 (Pharmacia) (0.6 X 150 cm, equilibrated in 4 M guanidine, 50 mM sodium acetate, pH 6.0, containing 0.5% Triton X-100) before and after treatment with Streptomyces hyaluronidase (50 mU/mI; Sigma, Poole, UK) for 16 hours [11] .
Co-culture of human mesothelial cells with peritoneal fluid, cytokines and growth factors
Human peritoneal mesothelial cells were established in 24-well plates and growth arrested as described above. The culture medium was then removed and the cells washed twice with PBS. The culture was then continued in serum-free medium containing different concentrations of cytokines or dialysate, suitably diluted, and D-[6-3HJ-glucosamine hydrochloride (25 iCi/ml). The level of HA synthesis was established by the incorporation of 3Hglucosamine into papain-resistant, hyaluronidase-degradable radiolabeled high molecular weight glycosaminoglycans (GAGs) as above.
In the experiments with the added cytokincs the level of HA was also measured using a specific ELISA. This assay was unsuitable to determine the effect of dialysate on HA synthesis because the fluid itself contains high levels of endogenous HA. Cell numbers were determined by direct counting using a modified Neuhauer hemocytometer. The cytokines were obtained from R&D Systems Europe, Ltd., Oxon, UK. lnterleukin-i receptor anatgonist was a gift of Dr. Luke O'Neill, Trinity College, Dublin, Ireland.
Determination of HA levels by ELISA
Prior to assay the culture medium was digested with papain and the HA was determined using an ELISA protocol as described by Forsang et al [18] . The assay involves the competition between HA adsorbed to microtiter plates and HA in solution for binding to the binding region of the Gi domain of aggrecan. This material was donated by Dr. M.T. Bayliss, Kennedy Institute, Hammersmith, England, UK. To assess the effect of serum on HA synthesis as determined by the ELISA, the FCS was passed over a DEAE-Sephacel column to remove any endogenous HA prior to culture with HPMC.
Determination of IL-i levels in dialysate IL-1 was determined by enzyme immunoassay, using kits obtained from Modyinex Diagnostis (Fleurs, Belgium) as described by Brauner, Hylander, and Wretlind [19] .
Statistics
Results are expressed as means SD and range as appropriate and compared using the Student's t-test.
Results
The determination of levels of hyaluronan (HA) The biosynthesis of HA by HPMC was determined by metabolic labeling of the cells with [3H]-glucosamine for 24 hours, followed by analysis of the labeled macromolecules extracted from the cell layer and culture medium after digestion with papain. The digested products were concentrated on a Mono-Q anion exchange column, and the bound material was eluted between 0.3 to 0.4 M NaCl ( The material from each fraction was also concentrated and assayed for HA using an ELISA employing the biotinylated Gi domain (HA-binding region) of aggrecan [18] . The elution profile determined with this assay confirmed the distribution and size of the metabolically labeled HA (data not shown). a dose of 10 ng/ml, there was approximately a 1.7 to 2.9-fold significant increase for each of these peptides. In contrast, IL-113 at the same dose dramatically increased the levels of [3H]HA. At a concentration of 10 nglml there was an eight-fold increase in HA synthesis compared to control cells. To confirm the above results, the HA levels after treatment with the different cytokines were also determined using the HA-binding assay. The levels of HA detected in the cells and medium treated with the different peptides confirmed the findings with the radiolabeling assay (Fig.  2) . The effect of IL-1p was both dose-and time-dependent (0 to 24 hr) ( Fig. 3) . Table 1 also indicates that FCS (10%) induced a 24.3-fold increase in 1-IA synthesis. Analysis of the data indicated that after treatment with IL-i j3 there was no change in the distribution of [3HJHA, and >95% was recovered in the culture medium.
Having determined that IL-I 13 greatly enhanced the synthesis of HA by HPMC, we next investigated the effect of interleukin-113 receptor antagonist (IL-1f3 RcA) on the up-regulation. Cells were treated with IL-1J3 (1 and 5 ng/ml) with and without IL-1p RcA (100 ng/ml). IL-1p RcA itself had no effect on the growth of the cells, nor was it toxic. Furthermore, the antagonist when added to the culture medium alone had no direct effect on the synthesis of HA. IL-1j3 RcA, however, did block the IL-1J3 dependent increase in {3H]-HA ( Fig. 4) . At a 100-fold excess the IL-1/3 RcA completely prevented the enhanced synthesis, whereas at a 20-fold excess the synthesis was reduced over control by 40%.
Co-culture of HPMC with peritoneal dialysate
To extend our studies on the metabolism of HA by HPMC, we co-cultured these cells with dialysate obtained from patients HA synthesis was measured as described in Fig. 1 . The results are expressed as means SD (N = 3) from three different cell lines. receiving CAPD for the treatment of end-stage renal failure. For this study, pooled dialysate was prepared from patients free of infection and from patients on day I and day 2 of an episode of peritonitis. As shown in Figure 5 , the separate addition of these three different sources of fluids induced an increase in HA synthesis. The response to the infected fluids, however, both from day 1 and day 2, was significantly greater than that of the non-infected. The stimulation of HA synthesis by both infected or non-infected dialysate was dependent on the concentration of the fluid and incubation time (data not shown). We were unable to demonstrate that unused dialysate at dilutions greater than one in five had any effect on HA synthesis by HPMC. Taken together, the above results suggest that the composition of the dialysate itself is not responsible for the observed enhanced synthesis of HA but rather an agent(s) acquired by the fluid during the period of dialysis is involved. Furthermore, dialysates from patients with peritonitis contain significantly higher amounts of this agent or agents. Since in the experiments described above we demonstrated that IL-1/3 had a potent effect on HA synthesis by HPMC, experiments were directed at determining whether IL-1/3 RcA caused a reduction in the level of HA extracted from the cell layer and culture medium. For these experiments, dilutions of dialysate (1/20 to 1/2) were employed and incubated with and without 100 nglml of IL-Ip RcA. Figure 6 . clearly shows that the response of the cells to infected fluid was reduced with an increasing ratio of the IL-1f3 RcA to dialysate. When the incubation was undertaken with 1 in 20 dilution of dialysate, the effect of the antagonist was to reduce the synthesis of HA by 95%.
In contrast, using the same dilutions and concentration of IL-1RcA, there was little or no reduction in the synthesis of HA with the non-infected fluid. This result suggests that IL-lp is not the agent responsible for the small increase in HA synthesis induced by non-infected fluid, as recorded in Figure 5 .
To further extend the above observations, we measured the levels of IL-1f3 in both sources of dialysate. The average levels in dialysate from patients with infection were between 18 to 40 pg/ml (average, 24 pg/mI; N = 8) for the first day of the infection. For day 2 of infection the levels in the dialysate of two patients investigated were lower (12 and 13.5 pg/ml, respectively). In contrast, the levels in fluid from six patients without peritonitis were undetectable. These findings are in agreement with the recent report by Brauner, Hylander, and Wretlind [19] .
Analysis of the 311-labeled HA extracted from control and stimulated cells
[3H]-HA derived from control cells and cells stimulated with lL-113 (10 ng/ml), non-infected and infected dialysate, and FCS were analyzed on an analytical Sephacryl-500 column. Comparison of the individual profiles confirmed that the size distribution of the [3H]-HA did not vary from control cells or cells grown in the presence of FCS (data not shown). The profiles failed to show the appearance of any lower molecular weight HA, nor was there any evidence of degradation products of HA.
Discussion
In this study we demonstrate that HPMC co-cultured with IL-1/3 induces a significant increase in HA levels, whereas PDGFbh, TGF-13, TNF-cs and IL-6 were all less effective. The relative increase in HA synthesis was demonstrated by using two different approaches, both of which gave comparable results for each cytokine and growth factor studied. At a dose of 10 ng/ml, IL-lp was capable of up-regulating HA synthesis by as much as eightfold, whereas with all the other factors investigated the increase was about two-fold. Analysis of the molecular weight of the HA synthesized by the cells co-cultured with IL-113 indicated that it was identical in size to HA from control cells. Furthermore, with both control and cytokine stimulated cells the majority of the HA (>95%) was located in the culture medium. These findings minimize potential ancillary effects, such as changes in metabolism, which contribute to the accumulation of HA. Finally, the results with IL-1/3 and the other cytokine and growth factors were not explained by changes in cell number.
HA is synthesized by a membrane bound enzyme, hyaluronan synthetase [20] [21] [22] , through the addition of monosaccharides to the reducing end while the polysaccharide is extruded through the plasma membrane and shed into the extracellular space. The activity of the HA synthetase is regulated by a number of different cytokines and growth factors alone or in combination, and for most of these factors has been shown to be directly related to the synthesis of the protein [13, 15] . To date, the factors investigated include TGF-13, TNF, and bFGF, as well as lymphotoxin and is-interferon [13, 15, 16, 23, 24] . The cell systems studied include synovial lining cells, ovarian cells from different sources, and human pleural mesothelial cells. With all these cells the effect of co-culture with the above factors was to increase HA synthesis by up to two-fold. The results from the present investigation for PDGF-bb, TGF-p and TNF-a are in keeping with this level of increase and furthermore indicate that IL-6 induces a similar response. The synthesis of HA in response to IL-lp is less well-documented, but in human chorionic cells [25] , rat ovarian cells [26] and synovial fibroblastic cells [27] , this cytokine appears to play a pivotal role in the accelerated biosynthesis and secretion of HA. A preliminary report has indicated that IL-1 (1 ng/ml) caused a small increase in HA synthesis in human mesothelial cells [28] . These experiments, however, were undertaken with cells grown in 10% FCS, and therefore already conditioned to synthesize HA. Our experiments were undertaken with quiescent cells and clearly show that IL-lp stimulates HPMC to synthesize HA in a dose-and time-dependent manner. Furthermore, this increase could be completely negated by IL-lp RcA.
The mechanism of regulation of HA by IL-1/3 in mesothelial [16, 29] . The IL-1p accelerated HA synthesis in chorionic cells is also accompanied by increased hyaluronate synthetase activity, which again in part appears to be regulated by protein kinase c [25] .
In the present study, we have also investigated the effect of dialysate from patients receiving CAPD on HA synthesis by resting HPMC. The results from these experiments show that, whereas non-infected fluid promoted very little HA accumulation, infected fluid initiated a dramatic increase in extracellular HA. This preferential promotion of HA by the dialysate of patients with active peritonitis could be inhibited by the inclusion of IL-1J3 RcA in the incubation medium. Furthermore, IL-113 was detected in dialysate from patients with peritonitis while it was absent in healthy patients. These results, taken together with the finding discussed above, that among a number of different factors investigated IL-1/3 was the most effective in the up-regulation of HA by HPMC, suggest that the same eytokine is the principal agent present in infected fluid to explain our previous findings that HA levels are elevated in patients with peritonitis [ii] . It was also shown that the receptor antagonist had little effect on the small increase in HA synthesis initiated by non-infected fluid, implying that IL-1f3 is not present in non-infected dialysate. It is also possible that in non-infected fluid the levels of cytokine are too low to invoke a significant response, or that any functional effect of peritoneal IL-1/3 is blocked by IL-i/3 RcA. It has been demonstrated that in vitro, to achieve a 50% reduction in a physiological response to IL-113, a 100-fold excess of antagonist is required [301. The levels of IL-1f3 and its specific antagonist have not been extensively studied in CAPD patients; however, two recent reports have indicated that both of these molecules are significantly elevated in the serum and dialysate of patients with infection compared to those without peritonitis [19, 31] . Our findings with the levels of IL-113 are in agreement with both these groups. A finding in both the above reports is relevant to the present studies, in that IL-1f3 RcA, but not IL-113, was detected in dialysate from peritonitis-free patients. This could well explain the relatively low stimulation of HA synthesis by non-infected dialysate. From the levels of antagonist and cytokine in the infected dialysate from these studies it is difficult to predict if the fluids would have an effect on HA synthesis (see above, and [30] ). To further understand the function of IL-1/3 in the inflammatory response to bacterial infection or damage to the mesothelium with long periods of dialysis, more information on the relative levels of the cytokine and its antagonists, including their bio-availability activity, is required. In addition, some information is required either to support or eliminate a role for cytokines other than IL-I 13 present in peritoneal fluid in the regulation of HA synthesis in peritonitis.
The implied role for IL-i j3 in the regulation of HA levels within the peritoneum raises the question as to the source of this cytokine. Two possibilities exist: the HPMC themselves and peritoneal macrophages. HPMC produce relatively low levels of IL-113, but the levels are raised in cells treated with exogenous IL-i/3, TNF-a or LPS [32, 33] It is worth recalling that stimulation with a combination of LPS and IL-1f3 or LPS and TNF-c had a significant synergistic effect on cytokine production [33] . It is also interesting to note that this cytokine is able to act in a paracrine manner to up-regulate the expression of genes for several different cytokines and growth factors, including IL-1f3 itself [32] .
HPMC are also a source of other cytokines, including TNF-a and IL-fl [34] , and their levels in the peritoneum are raised in peritonitis . The peritoneal macrophage is the predominant cell in the peritoneum of patients undergoing CAPD and forms the first line of defense in bacterial infection [38] [39] [40] . When appropriately stimulated, these cells secrete a host of proinflammatory molecules, including IL-1f3. This and other cytokines released by peritoneal macrophages also have the potential to interact with the resident peritoneal mesothelial cells, and thus form part of a peritoneal cytokine network [34] . At present it is not known the extent to which activated peritoneal macrophages can enhance HA synthesis by HPMC. Since they secrete IL-113, and given the observations in the present report, it is likely that macrophages could play a key role in controlling the contribution of HPMC to the overall levels of HA in the peritoneum.
In conclusion, the results reported in this paper permit the speculation that IL-ip is a major stimulator of HA in the peritoneum during episodes of peritonitis. The implication of such a response remains to be decided, but since HA is an important component of the early events of wound healing [1], a role for IL-113 in the control HA metabolism of the mesothelium is possible. Recently, HA has been shown to be a constituent of the vascular endothelial basement membrane, and that its selective removal effects the passage of solute through the endothelium liquid-exchange barrier [41] . The composition of the peritoneal liquid-exchange barrier is not known in detail, but histochemical studies have demonstrated the existence of anionic sites along the peritoneal basement membrane and part of the protective glycocalyx that surrounds mesothelial cells [42] . In vitro studies have clearly identified HA as a critical component of the glycocalyx of cells [4345] , which protects the cell from viral infection [43] and the cytotoxic effect of lymphocytes [46, 47] . More importantly, acute experimental peritonitis induces a reduction of the anionic sites of the mesothelial cell glycocalyx, as well as the microvascular mesothelial barrier [48] . The apparent rapid and early response of HA synthesis by HPMC to IL-1/3 described in these studies could suggest an attempt by these cells to limit the consequences of peritonitis.
